Selective removal of decayed tissue in back teeth
Carious Tissue Selective Removal on Permanent Posterior Teeth. A Randomized Controlled Clinical Study.
This study tests whether using different materials to remove decayed tissue from back teeth helps patients feel better and have better results over time.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 111 (estimated) |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Sponsor | Universitat Internacional de Catalunya Academic / other |
| Locations | 1 site (Sant Cugat del Vallès, Barcelona) |
| Trial ID | NCT04533113 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of selectively removing carious tissue from deep lesions in posterior teeth using three different liner materials: VitreBond ™Plus, BioDentine™, and Theracal™ LC. It is a prospective randomized controlled study conducted at the Universitat Internacional de Catalunya, where patients will be monitored for post-operative pain and clinical success over one, two, and five years. The study aims to determine if there are significant differences in treatment success rates among the three materials used.
Who should consider this trial
Good fit: Ideal candidates are patients with posterior teeth diagnosed with normal pulp or reversible pulpitis who can provide informed consent.
Not a fit: Patients with systemic diseases, irreversible pulpitis, or those who are pregnant may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to improved treatment outcomes and reduced post-operative pain for patients with deep dental caries.
How similar studies have performed: Other studies have explored selective carious tissue removal, but the specific comparison of these three materials is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients that demonstrate understanding of the study and willingness to participate as evidenced by signing the voluntary informed consent and received a signed and dated copy of the informed consent form. * Understands and is willing to comply with all study procedures and restrictions. * Not presence of clinically significant and relevant abnormalities of clinical history or oral examination. * Diagnosis of normal pulp or reversible pulpitis. * No presence of periapical periodontitis * Posterior teeth Exclusion Criteria: General: Patients with systemic diseases, diabetes, immunocompromised and pregnant women, or any clinically significant or relevant oral abnormalities. Specific: Impossibility of restoration, diagnosis of irreversible pulpitis or necrosis, preoperative pain
Where this trial is running
Sant Cugat del Vallès, Barcelona
- Universitat Internacional de Catalunya — Sant Cugat del Vallès, Barcelona, Spain (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.